NMNAT1

Chr 1AR

nicotinamide nucleotide adenylyltransferase 1

Also known as: LCA9, NMNAT, PNAT1, SHILCA

This nuclear enzyme catalyzes the formation of NAD+ from nicotinamide mononucleotide and ATP, playing a critical role in nuclear energy metabolism and neuroprotection against axonal degeneration. Mutations cause Leber congenital amaurosis 9 (severe early-onset retinal dystrophy leading to blindness in infancy) and a multisystem disorder involving spondyloepiphyseal dysplasia, sensorineural hearing loss, and intellectual disability. Inheritance is autosomal recessive.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismARLOEUF 0.882 OMIM phenotypes
Clinical SummaryNMNAT1
🧬
Gene-Disease Validity (ClinGen)
NMNAT1-related retinopathy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.04) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
110 unique Pathogenic / Likely Pathogenic· 93 VUS of 279 total submissions
📖
GeneReview available — NMNAT1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.88LOEUF
pLI 0.035
Z-score 1.85
OE 0.38 (0.190.88)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.63Z-score
OE missense 0.86 (0.740.99)
129 obs / 150.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.38 (0.190.88)
00.351.4
Missense OE0.86 (0.740.99)
00.61.4
Synonymous OE0.89
01.21.6
LoF obs/exp: 4 / 10.4Missense obs/exp: 129 / 150.6Syn Z: 0.64
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveNMNAT1-related Leber congenital amaurosisLOFAR

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.74top 25%
GOF
0.5856th %ile
LOF
0.2678th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

279 submitted variants in ClinVar

Classification Summary

Pathogenic68
Likely Pathogenic42
VUS93
Likely Benign60
Benign2
Conflicting9
68
Pathogenic
42
Likely Pathogenic
93
VUS
60
Likely Benign
2
Benign
9
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
17
10
41
0
68
Likely Pathogenic
4
29
9
0
42
VUS
3
73
17
0
93
Likely Benign
0
2
20
38
60
Benign
0
0
2
0
2
Conflicting
9
Total241148938274

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NMNAT1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →